ASBMB’s first meeting in China will cover the molecular biology, pathogenesis and antiviral host defenses of a range of human viruses.
Last year, for the first time ever, General Motors sold more cars in China than in the United States. Last year also was the first time that China’s economy grew to a size larger than Japan’s. This year will mark another first. The American Society of Biochemistry and Molecular Biology will be holding its first ever meeting in China. The meeting, “Recent advances in pathogenic human viruses,” will be held July 24 to 26 in Guangzhou. It will be sharing the Baiyun Convention Center with a simultaneous larger molecular and cellular biology meeting, The Society of Chinese Bioscientists in America Thirteenth International Symposium. Guangzhou, the third-largest city in China, is beautifully situated on the Pearl River within 100 miles of Hong Kong. The city is easily accessible through its modern international airport as well as by train from Hong Kong.
The meeting will cover the molecular biology, pathogenesis and antiviral host defenses of a range of human viruses, including influenza virus, human immunodeficiency virus, herpesviruses, human papillomavirus, and hepatitis B and C viruses. We are excited by the prospect of having a good mix of speakers and attendees from North America, Australia and Asia. If you are interested in virology, antiviral immunity or host defenses, this is a small, focused meeting that you will not want to miss. We welcome your submission of abstracts for consideration as short oral or poster presentations by the submission deadline of April 30, 2011. Space is limited, so act quickly to reserve your spot.
The meeting’s keynote speaker will be Michael M. C. Lai, who currently is a distinguished investigator at Academia Sinica in Taiwan. For many years, Lai was a Howard Hughes Medical Institute investigator at the University of Southern California as well as a long-standing editor of Virology. Lai will present his latest findings on the molecular pathogenesis of hepatitis C virus. Several other outstanding plenary speakers also have committed to attend this meeting, including Elliott Kieff of Harvard University, Dong-Yan Jin of the University of Hong Kong, Bernard Moss of the National Institute of Allergy and Infectious Diseases, Bryan Williams of Monash University in Australia, and Diane Hayward of the Johns Hopkins University.
As part of a new initiative by the Journal of Biological Chemistry, invited speaker and JBC Associate Editor Charles Samuel of the University of California, Santa Barbara will present The Journal of Biological Chemistry/Herbert Tabor Young Investigator Award to one outstanding participant presenting research at the meeting. This prestigious award will include a $1,500 prize and a plaque.
If you never have visited China, this is an opportunity for you to attend a top-notch small virology conference, discuss cutting-edge science with enthusiastic colleagues from around the world and experience first-hand a rapidly modernizing Chinese culture. And if you have been to China, we know you will want to go back again for this event.
Ni hao! We look forward to seeing you in July in Guangzhou.
Kuan-Teh Jeang (email@example.com) is chief of the molecular virology section at National Institute of Allergy and Infectious Diseases, National Institutes of Health. Douglas Lowy (firstname.lastname@example.org) is chief of the laboratory of cellular oncology at the National Cancer Institute, NIH.